Jacobi Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Jacobi Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-100	Closed	-$12K	–	1236
2021 Q3	$12K	Buy	+100	New	+$11K	﹤0.01%	1015
2020 Q4	–	Sell	-400	Closed	-$45K	–	1372
2020 Q3	$45K	Hold	400	–	–	0.01%	519
2020 Q2	$40K	Hold	400	–	–	0.01%	518
2020 Q1	$26K	Hold	400	–	–	0.01%	520
2019 Q4	$24K	Sell	400 -700	-64%	-$43.2K	﹤0.01%	595
2019 Q3	$65K	Sell	1,100 -1,320	-55%	-$84.3K	0.01%	409
2019 Q2	$156K	Sell	2,420 -2,930	-55%	-$189K	0.03%	299
2019 Q1	$340K	Buy	5,350 +1,380	+35%	+$72.5K	0.09%	166
2018 Q4	$151K	Sell	3,970 -1,300	-25%	-$45.9K	0.04%	252
2018 Q3	$226K	Buy	5,270 +1,520	+41%	+$53.1K	0.06%	203
2018 Q2	$83K	Buy	+3,750	New	+$46.1K	0.02%	349

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Jacobi Capital Management's TNDM Position: Q4 2021 in Review

Jacobi Capital Management sold out of Tandem Diabetes Care (TNDM) in Q4 2021, closing a stake of 100 shares — an estimated $12K sold.

Jacobi Capital Management first reported a position in TNDM in Q2 2018 and held it in 11 quarters. The position peaked at $340K in Q1 2019. 388 funds tracked by Wall St. Rank hold TNDM as of Q4 2021.

Jacobi Capital Management reported no remaining Tandem Diabetes Care position as of Q4 2021 after selling out during the quarter.
Jacobi Capital Management sold 100 Tandem Diabetes Care shares in Q4 2021, an estimated $12K.
Jacobi Capital Management first reported a position in Tandem Diabetes Care in Q2 2018 and held it in 11 quarters.
Jacobi Capital Management's Tandem Diabetes Care position peaked at $340K in Q1 2019.
388 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2021.

Based on Jacobi Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.